NCT05405166 SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05366764 First-in-human Study of SAR443765 in Healthy Participants and in Asthmatic Participants Status COMPLETED Phase PHASE1
NCT05359276 Data Analysis of Adult and Pediatric Participants With Acid Sphingomyelinase Deficiency (ASMD) on Early Access to Olipudase Alfa in France Status COMPLETED Phase N/A
NCT05326412 Mechanistic Study of the Effect of Itepekimab on Airway Inflammation in Patients With COPD Status COMPLETED Phase PHASE2
NCT05302297 Comparative Efficacy of Cemiplimab to Historical Standard of Care in France Status COMPLETED Phase N/A
NCT05298683 A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor Status NOT_YET_RECRUITING Phase PHASE2
NCT05283915 Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Mild Hepatic Impairment Compared to Participants With Normal Hepatic Function Status COMPLETED Phase PHASE1
NCT05282030 Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Renal Impairment Compared to Healthy Participants. Status COMPLETED Phase PHASE1
NCT05280548 A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05279833 Systematic Review and Meta-Analysis of Multaq® for Safety in Atrial Fibrillation Status COMPLETED Phase N/A
NCT05264662 Pertussis Vaccination Among HIV-infected and HIV-uninfected Pregnant Women Status COMPLETED Phase PHASE4
NCT05263206 Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC) Status RECRUITING Phase PHASE3
NCT05263193 Retrospective Study on Caplacizumab-treated Pediatric Patients With Immune-mediated Thrombocytopenic Purpura (iTTP) Status COMPLETED Phase N/A
NCT05245071 Tusamitamab Ravtansine in NSQ NSCLC Participants With Negative or Moderate CEACAM5 Expression Tumors and High Circulating CEA Status TERMINATED Phase PHASE2
NCT05237284 Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS) Status TERMINATED Phase PHASE2
NCT05235724 A Study to Assess the Reliability/Feasibility of Using Emerald Touchless Sensor for Scratching and Sleep Quantification in a Subset of Participants From PEDISTAD Study (OBS15333; NCT03687359) Status COMPLETED Phase N/A
NCT05231668 Single Ascending Dose Study of SAR439459 in Adults With Osteogenesis Imperfecta (OI) Status TERMINATED Phase PHASE1
NCT05222906 Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3 Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05214326 A Study to Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Male and Female Participants of Atleast 12 Years Old Receiving Dupilumab Injections in Gulf Countries Status COMPLETED Phase N/A
NCT05206773 A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age With Fabry Disease Status ACTIVE_NOT_RECRUITING Phase PHASE3